🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
Breast cancer is one of the most common cancers in women. 20-30 % of all br...
Status
Completed
Location
Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde
Start Date
2020-12-22
Trial ID
NCT04681768
Treatments Being Tested
The goal of this clinical study is to determine whether monitoring ctDNA an...
Status
Not Yet Recruiting
Location
Nagoya City University
Start Date
2026-01-10
Trial ID
NCT07292207
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of abemacicl...
Status
Recruiting
Location
CHU de Liège
Start Date
2023-11-30
Trial ID
NCT05872204
Treatments Being Tested
This is a study in adult patients with different types of cancer. The purpo...
Status
Completed
Location
University of California Los Angeles
Start Date
2017-05-04
Trial ID
NCT03099174
Treatments Being Tested
A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2021-01-01
Trial ID
NCT04852081
Treatments Being Tested
The purpose of this study is to measure how much abemaciclib gets into the ...
Status
Completed
Location
Daytona Beach Clinical Research Unit
Start Date
2016-02
Trial ID
NCT02672423
Treatments Being Tested
This is a phase 2, open-label, singled-arm clinical trial determining effic...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Start Date
2022-08-31
Trial ID
NCT05524584
Treatments Being Tested
This is a Study to Evaluate the Efficacy and Safety of Multiple Combination...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center, Shanghai
Start Date
2025-06-01
Trial ID
NCT07002177
Treatments Being Tested
This is a multicenter, randomized, 2 arm, open label, phase II study. It is...
Status
Completed
Location
Instituto Europeo di Oncologia
Start Date
2021-06-02
Trial ID
NCT04603183
Treatments Being Tested